CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 27, 2026, 12:28 PM EST
CNBX Pharmaceuticals Employees
CNBX Pharmaceuticals had 1 employees as of August 31, 2025. The number of employees decreased by 1 or -50.00% compared to the previous year.
Employees
1
Change
-1
Growth
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$393,343
Market Cap
130.62K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 1 | -1 | -50.00% |
| Feb 28, 2025 | 1 | -1 | -50.00% |
| Aug 31, 2024 | 2 | 0 | - |
| Feb 29, 2024 | 2 | -1 | -33.33% |
| Aug 31, 2023 | 2 | -3 | -60.00% |
| Feb 28, 2023 | 3 | - | - |
| Nov 30, 2022 | 5 | -5 | -50.00% |
| Aug 31, 2022 | 5 | -5 | -50.00% |
| Aug 31, 2021 | 10 | 1 | 11.11% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Scorpius Holdings | 91 |
| Synairgen | 34 |
| Vincerx Pharma | 13 |
| Ocean Biomedical | 7 |
| Ampio Pharmaceuticals | 6 |
| Innovation Pharmaceuticals | 4 |
| GB Sciences | 2 |
| Actavia Life Sciences | 1 |
CNBX Pharmaceuticals News
- 3 years ago - Cannabis REITs: Smoked Out - Seeking Alpha
- 3 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
- 3 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
- 3 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
- 3 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
- 3 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
- 4 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
- 4 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire